|
ATBPF
|
I enjoyed the depth of your post, but why would the market cap immediately...
|
|
ATBPF
|
I've been tough on management, but I really don't think they want to...
|
|
ATBPF
|
To the contrary, I think you could replace Dan with the CEO of most any...
|
|
ATBPF
|
Wondering if anyone has looked into PLX Pharma (PLXP), as they seem to be...
|
|
ATBPF
|
If you're talking about an upfront payment on a licensing deal, I don'...
|
|
ATBPF
|
I think the plan is to use that professor's lab/research to help expand...
|
|
ATBPF
|
TRIL hasn't done 5x this month. Not even in the past 6 months...
|
|
ATBPF
|
I agree. Given how many times Dan has emphasized that they want their...
|
|
ATBPF
|
Obviously Dan isn't going anywhere - I never disputed that. I...
|
|
ATBPF
|
Since you dodged all of the questions I asked you, it seems that our...
|
|
ATBPF
|
Numerous biotech companies have experienced obstacles like Antibe's (or...
|
|
ATBPF
|
Did you check my post history before leveling that accusation? Or did...
|
|
ATBPF
|
I'm familiar enough with biotech to know that this management team is...
|
|
ATBPF
|
What is the true motivation of your dismissing legitimate criticisms of...
|
|
ATBPF
|
Very interesting, thank you. I was under impression that $4 was the...
|
|
ATBPF
|
They need some kind of impactful news to move share price in order to uplist...
|
|
ATBPF
|
Momenta and Antibe are two totally different companies; their pipelines are...
|
|
ATBPF
|
Much of the rise for MCRB was due to a short squeeze. &...
|
|
ATBPF
|
That is an important point. Since Insiders own that much, it tells you...
|
|
ATBPF
|
The company's science and trial data earns them credibility. &...
|